Supercritical fluid technologies and tissue engineering scaffolds
Source abstract
Abstract
Supercritical fluid (SCF) processing methods possess advantages over standard processing methods for the production of scaffolds for use in tissue engineering. Advantages include the absence of organic solvents, the ability to incorporate delicate biologicals without loss of activity, and control over the morphology of an internal porous architecture. This review describes SCF processing methods of relevance to tissue engineering and controlled release strategies, with focus on the incorporation of bioactives such as protein growth factors.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Polymer Foaming and Composites · Phase Equilibria and Thermodynamics · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (95)
Show source-provided references
1. Tissue engineering––current challenges and expanding opportunities10.1126/science.1069210 ↗
2. Recent advances in tissue engineering: an invited review10.1615/JLongTermEffMedImplants.v12.i1.20 ↗
3. Transplantation of cells in matrices for tissue regeneration10.1016/S0169-409X(98)00025-8 ↗
4. Stem-cell competition10.1038/418025a ↗
5. Stem cells in tissue engineering10.1038/35102181 ↗
6. Synthetic skin10.1109/MSPEC.2002.1088442 ↗
7. Bioactive biomaterials10.1016/S0958-1669(99)80021-4 ↗
8. Growth factor release from tissue engineering scaffolds10.1211/0022357011777963 ↗
9. Development of growth factor fusion proteins for cell-triggered drug delivery10.1096/fj.00-0564fje ↗
10. Polymeric biomaterials10.1016/S1359-6454(99)00299-2 ↗
11. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks10.1016/S0142-9612(02)00420-9 ↗
12. Chemico–physico properties of hyaluronan-based sponges10.1002/1097-4636(20001215)52:4<695::AID-JBM14>3.0.CO;2-G ↗
13. Collagen fabrics as biomaterials10.1002/bit.260430813 ↗
14. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication10.1016/S0142-9612(02)00528-8 ↗
15. Hepatocyte behaviour within three-dimensional porous alginate scaffolds10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2 ↗
16. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering10.1096/fasebj.13.15.2214 ↗
17. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension10.1038/74473 ↗
18. Development of fibrin derivatives for controlled release of heparin-binding growth factors10.1016/S0168-3659(99)00221-7 ↗
19. Development of biocompatible synthetic extracellular matrices for tissue engineering10.1016/S0167-7799(98)01191-3 ↗
20. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives10.1097/00003086-199011000-00043 ↗
21. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
22. Synthetic biodegradable polymers for orthopaedic applications10.1097/00003086-199910001-00012 ↗
23. Structure property relationships in the case of the degradation of massive aliphatic poly(alpha-hydroxy acids) in aqueous media. 1. Poly(dl-lactic acid)10.1007/BF00700871 ↗
24. Host response to tissue engineered devices10.1016/S0169-409X(98)00023-4 ↗
25. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation10.1097/00006534-199111000-00001 ↗
26. Tissue engineering by cell transplantation using degradable polymer substrates10.1115/1.2891228 ↗
27. Stabilized polyglycolic acid fibre-based tubes for tissue engineering10.1016/0142-9612(96)85756-5 ↗
28. Biodegradable polymer scaffolds for tissue engineering10.1038/nbt0794-689 ↗
29. In vivo evaluation of poly(l-lactic acid) porous conduits for peripheral nerve regeneration10.1016/S0142-9612(99)00010-1 ↗
30. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F ↗
31. Cartilage formation by cultured chondrocytes in a new scaffold made of poly(l-lactide-ε-caprolactone) sponge10.1053/joms.2000.7262 ↗
32. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(l-lactide) substrates allowing regionally selective cell adhesion10.1163/156856298X00451 ↗
33. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds10.1016/S0142-9612(02)00276-4 ↗
34. Emulsion copolymerization of d,l-lactide and glycolide in supercritical carbon dioxide10.1002/1099-0518(20010215)39:4<562::AID-POLA1027>3.0.CO;2-L ↗
35. Precipitation polymerization of methyl methacrylate in tetrahydrofuran with compressed CO2 as antisolvent10.1002/app.11978 ↗
36. Preparation of drug delivery systems using supercritical fluid technology
37. Improving drug delivery using polymers and supercritical fluid technology10.1071/CH02058 ↗
38. Formation of microparticulate protein powders using a supercritical fluid antisolvent10.1002/bit.260410308 ↗
39. Precipitation of proteins in supercritical carbon dioxide10.1021/js950482q ↗
40. The use of supercritical fluids as reaction medium for ceramic powder synthesis
41. Environmentally friendly coatings using carbon dioxide as a carrier medium10.1023/A:1020874532674 ↗
42. Supercritical fluid technology in textile processing: an overview10.1021/ie0002475 ↗
43. Polymer processing with supercritical fluids
44. Imaging polymers with supercritical carbon dioxide10.1002/adma.19970091309 ↗
45. Particle design using supercritical fluids: literature and patent survey10.1016/S0896-8446(01)00064-X ↗
46. Formation of microcapsules of medicines by the rapid expansion of a supercritical solution with a nonsolvent10.1002/app.12201 ↗
47. Microencapsulation of naproxen using rapid expansion of supercritical fluids10.1021/bp9600492 ↗
48. Applications of supercritical fluids in controlled release of drugs
49. Improvement of nifedipine dissolution characteristics using supercritical CO210.1016/S0378-5173(96)04838-7 ↗
50. Size controlled production of biodegradable microparticles with supercritical gases10.1016/S0939-6411(97)00124-0 ↗
51. Production of protein-loaded polymeric microcapsules by compressed CO2 in a mixed solvent10.1021/ie0004904 ↗
52. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques10.1002/jps.1113 ↗
53. CO2 and fluorinated solvent-based technologies for protein microparticle production from aqueous solutions10.1021/bp0255513 ↗
54. Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly(l-lactide) microparticles10.1023/A:1011991808423 ↗
55. The effect of initial drop size on particle size in the supercritical antisolvent precipitation (SAS) technique10.1016/S0896-8446(02)00034-7 ↗
56. Aerosol solvent extraction system––a new microparticle production technique10.1016/0378-5173(93)90131-X ↗
57. Preparation of biodegradable microparticles using solution enhanced dispersion by supercritical fluids (SEDS)10.1023/A:1018868423309 ↗
58. Novel approach to fabricate porous sponges of poly(d,l-lactic-co-glycolic acid) without the use of organic solvents10.1016/0142-9612(96)87284-X ↗
59. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering10.1016/S0142-9612(00)00120-4 ↗
60. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials10.1039/b008188o ↗
61. Controllable delivery of non-viral DNA from porous scaffolds10.1016/S0168-3659(02)00369-3 ↗
62. Carbon dioxide extraction of residual chloroform from biodegradable polymers10.1002/jbm.10209 ↗
63. Use of supercritical CO2 for bone delipidation10.1016/0142-9612(94)90162-7 ↗
64. Histological integration of allogeneic cancellous bone tissue treated by supercritical CO2 implanted in sheep bones10.1016/S0142-9612(98)00124-0 ↗
65. Porous materials and supercritical fluids10.1002/adma.200300380 ↗
66. Generation of microcellular polymeric foams using supercritical carbon dioxide. I. Effect of pressure and temperature on nucleation10.1002/pen.760341407 ↗
67. The role of gas dissolution and induced crystallization during microcellular polymer processing: a study of poly(ethylene terephthalate) and carbon dioxide systems10.1115/1.2804373 ↗
68. De Ponti R, Torricelli C, Martini A, Lardini E. Patent PCT/EP90/01895
69. Open pore biodegradable matrices formed with gas foaming10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E ↗
70. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold10.1006/excr.1999.4595 ↗
71. Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds10.1089/107632702753503045 ↗
72. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery10.1016/S0168-3659(99)00138-8 ↗
73. Engineering vascular networks in porous polymer matrices10.1002/jbm.10134 ↗
74. Polymeric system for dual growth factor delivery10.1038/nbt1101-1029 ↗
75. Drug-releasing scaffolds fabricated from drug-loaded microspheres10.1002/jbm.1251 ↗
76. Active growth factor delivery from poly(d,l-lactide-co-glycolide) foams prepared in supercritical CO210.1016/S0168-3659(99)00268-0 ↗
77. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification10.1016/S8756-3282(01)00617-2 ↗
78. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds10.1006/bbrc.2002.6623 ↗
79. Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold10.1016/S0006-291X(02)02561-5 ↗
80. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering10.1359/jbmr.2003.18.1.47 ↗
81. Supercritical fluids: a clean route to polymer synthesis and polymer processing
82. Novel osteoinductive biomimetic scaffolds stimulate human osteoprogenitor activity––implications for skeletal repair10.1080/713713599 ↗
83. Incorporation of proteins into polymer materials by a novel supercritical fluid processing method10.1002/adma.200290003 ↗
84. Production of different morphologies of biocompatible polymeric materials by supercritical CO2 antisolvent techniques10.1002/bit.1079 ↗
85. Generation of microcellular polymeric foams using supercritical carbon dioxide. 2. Cell-growth and skin formation10.1002/pen.760341408 ↗
86. Growth factor delivery for tissue engineering10.1023/A:1007502828372 ↗
87. Mandel FS, Popov VK, Howdle SM. Supercritical fluid assisted production of synthetic bone composites. In: 5th Meeting on Supercritical Fluids, Nice, 1998
88. Supercritical fluids: new solvents for polymer synthesis and polymer processing
89. Hao J et al. Control of poly (dl-lactic acid) particle size during spraying from a supercritical carbon dioxide environment. J Pharm Sci, in press
90. Porous polymer and cell composites that self-assemble in situ10.1002/adma.200390047 ↗
91. Rigid pore structure from highly swollen polymer gels10.1021/ma0119225 ↗
92. Chemico-physical properties of hyaluronan-based sponges10.1002/1097-4636(20001215)52:4<695::AID-JBM14>3.0.CO;2-G ↗
93. Hyaluronic acid-based polymers as cell carriers for tissue-engineering repair of bone and cartilage10.1002/jor.1100170209 ↗
94. Morphology and metabolism of hepatocytes cultured in Petri dishes on films and in non-woven fabrics of hyaluronic acid esters10.1016/S0142-9612(00)00228-3 ↗
95. Reconstructive surgery of the urethra: a pilot study in the rabbit on the use of hyaluronan benzyl ester (Hyaff-11) biodegradable grafts10.1007/BF01037930 ↗